Risk factors for primary site necrosis after definitive concurrent chemoradiotherapy in head and neck cancer

CONCLUSIONS: V70 ⩾79.8 mL is significantly related to the risk of developing PSN. These findings offer valuable clues for clinicians to minimize PSN incidence in HNC treated with curative CCRT.PMID:34806477 | DOI:10.1177/03008916211059852
Source: Tumori - Category: Cancer & Oncology Authors: Source Type: research